---
document_datetime: 2024-04-29 16:28:51
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/hexyon-epar-all-authorised-presentations_en.pdf
document_name: hexyon-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.6897727
conversion_datetime: 2025-12-22 08:56:18.729746
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form      | Route of Administration   | Immediate Packaging        | Content (concentration)   | Pack size                                          |
|------------------|-------------------|------------|--------------------------|---------------------------|----------------------------|---------------------------|----------------------------------------------------|
| EU/1/13/829/001  | Hexyon            | --¹        | Suspension for injection | Intramuscular use         | vial (glass)               | 0.5 ml                    | 10 vials                                           |
| EU/1/13/829/002  | Hexyon            | --¹        | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 1 pre-filled syringe                               |
| EU/1/13/829/003  | Hexyon            | --¹        | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 10 pre-filled syringes                             |
| EU/1/13/829/004  | Hexyon            | --¹        | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 1 pre-filled syringe + 1 needle                    |
| EU/1/13/829/005  | Hexyon            | --¹        | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 10 pre-filled syringes + 10 needles                |
| EU/1/13/829/006  | Hexyon            | --¹        | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 1 pre-filled syringe + 2 needles                   |
| EU/1/13/829/007  | Hexyon            | --¹        | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 10 pre-filled syringes + 20 needles                |
| EU/1/13/829/008  | Hexyon            | --¹        | injection                | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 50 pre-filled syringes                             |
| EU/1/13/829/009  | Hexyon            | --¹        | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 50 (5 x 10) pre-filled syringes                    |
| EU/1/13/829/010  | Hexyon            | --¹        | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | (multipack) 1 pre-filled syringe + 1 safety needle |

<div style=\"page-break-after: always\"></div>

| EU/1/13/829/011   | Hexyon   | --¹   | Suspension for injection   | Intramuscular use   | pre-filled syringe (glass)   | 0.5 ml   | 10 pre-filled syringes + 10 safety needles   |
|-------------------|----------|-------|----------------------------|---------------------|------------------------------|----------|----------------------------------------------|

--¹ One dose 1  (0.5 ml) contains: Diphtheria Toxoid not less than 20 IU   (30 Lf) Tetanus Toxoid                                                               not less than 40 IU   (10 Lf) Bordetella pertussis antigens Pertussis Toxoid 25 micrograms

Filamentous Haemagglutinin 25 micrograms Poliovirus (Inactivated) Type 1 (Mahoney) 29 D-antigen units Type 2 (MEF-1) 7 D-antigen units Type 3 (Saukett) 26 D-antigen units Hepatitis B surface antigen 10 micrograms Haemophilus influenzae type b polysaccharide 12 micrograms (Polyribosylribitol Phosphate) conjugated to Tetanus protein 22-36 micrograms

1  Adsorbed on aluminium hydroxide, hydrated (0.6 mg Al 3+ )